Literature DB >> 34280245

In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus.

Christina Holmboe Olesen1,2, Elias H Augestad1,2, Fulvia Troise3, Jens Bukh1,2, Jannick Prentoe1,2.   

Abstract

Hepatitis C virus (HCV) chronically infects 70 million people worldwide with an estimated annual disease-related mortality of 400,000. A vaccine could prevent spread of this pervasive human pathogen, but has proven difficult to develop, partly due to neutralizing antibody evasion mechanisms that are inherent features of the virus envelope glycoproteins, E1 and E2. A central actor is the E2 motif, hypervariable region 1 (HVR1), which protects several non-overlapping neutralization epitopes through an incompletely understood mechanism. Here, we show that introducing different HVR1-isolate sequences into cell-culture infectious JFH1-based H77 (genotype 1a) and J4 (genotype 1b) Core-NS2 recombinants can lead to severe viral attenuation. Culture adaptation of attenuated HVR1-swapped recombinants permitted us to identify E1/E2 substitutions at conserved positions both within and outside HVR1 that increased the infectivity of attenuated HVR1-swapped recombinants but were not adaptive for original recombinants. H77 recombinants with HVR1 from multiple other isolates consistently acquired substitutions at position 348 in E1 and position 385 in HVR1 of E2. Interestingly, HVR1-swapped J4 recombinants primarily acquired other substitutions: F291I (E1), F438V (E2), F447L/V/I (E2) and V710L (E2), indicating a different adaptation pathway. For H77 recombinants, the adaptive E1/E2 substitutions increased sensitivity to the neutralizing monoclonal antibodies AR3A and AR4A, whereas for J4 recombinants, they increased sensitivity to AR3A, while having no effect on sensitivity to AR4A. To evaluate effects of the substitutions on AR3A and AR4A binding, we performed ELISAs on extracted E1/E2 protein and performed immunoprecipitation of relevant viruses. However, extracted E1/E2 protein and immunoprecipitation of HCV particles only reproduced the neutralization phenotypes of the J4 recombinants. Finally, we found that the HVR1-swap E1/E2 substitutions decrease virus entry dependency on co-receptor SR-BI. Our study identifies E1/E2 positions that could be critical for intra-complex HVR1 interactions while emphasizing the need for developing novel tools for molecular studies of E1/E2 interactions.

Entities:  

Year:  2021        PMID: 34280245     DOI: 10.1371/journal.ppat.1009720

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  57 in total

1.  A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.

Authors:  Yimin Tong; Qingchao Li; Rui Li; Yongfen Xu; Yu Pan; Junqi Niu; Jin Zhong
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

Review 2.  Global Elimination of Chronic Hepatitis.

Authors:  David L Thomas
Journal:  N Engl J Med       Date:  2019-05-23       Impact factor: 91.245

3.  Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.

Authors:  Judith M Gottwein; Troels K H Scheel; Benoit Callendret; Yi-Ping Li; Heather B Eccleston; Ronald E Engle; Sugantha Govindarajan; William Satterfield; Robert H Purcell; Christopher M Walker; Jens Bukh
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

4.  Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.

Authors:  Jannick Prentoe; Stéphanie B N Serre; Santseharay Ramirez; Alfredo Nicosia; Judith M Gottwein; Jens Bukh
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

5.  Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.

Authors:  Erick Giang; Marcus Dorner; Jannick C Prentoe; Marlène Dreux; Matthew J Evans; Jens Bukh; Charles M Rice; Alexander Ploss; Dennis R Burton; Mansun Law
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-04       Impact factor: 11.205

6.  Hepatitis C virus E2 envelope glycoprotein core structure.

Authors:  Leopold Kong; Erick Giang; Travis Nieusma; Rameshwar U Kadam; Kristin E Cogburn; Yuanzi Hua; Xiaoping Dai; Robyn L Stanfield; Dennis R Burton; Andrew B Ward; Ian A Wilson; Mansun Law
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

7.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

8.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  A Biologically-validated HCV E1E2 Heterodimer Structural Model.

Authors:  Matteo Castelli; Nicola Clementi; Jennifer Pfaff; Giuseppe A Sautto; Roberta A Diotti; Roberto Burioni; Benjamin J Doranz; Matteo Dal Peraro; Massimo Clementi; Nicasio Mancini
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

10.  Building a mechanistic mathematical model of hepatitis C virus entry.

Authors:  Mphatso Kalemera; Dilyana Mincheva; Joe Grove; Christopher J R Illingworth
Journal:  PLoS Comput Biol       Date:  2019-03-18       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.